Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
FDA Vaccine Panel Meeting To Discuss Flu Shots Reportedly Canceled
02:53am, Thursday, 27'th Feb 2025
A meeting of the Food and Drug Administration's vaccine advisory committee to discuss the next season's flu vaccine has reportedly been canceled, the second such disruption of a meeting involving vacc
Summit Incurs In-Line Q4 Loss, Inks Collaboration Deal With Pfizer
09:40am, Tuesday, 25'th Feb 2025
SMMT's Q4 results meet estimates. The company signs a deal with Pfizer that expands ivonescimab's development beyond the NSCLC indication.
HONG KONG , Feb. 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a
Pfizer names former FDA director Patrizia Cavazzoni as chief medical officer
11:31am, Monday, 24'th Feb 2025
Pfizer said on Monday former head of FDA's drug center, Patrizia Cavazzoni, will join the drugmaker as chief medical officer.
Pfizer: What The Summit Therapeutics Deal Brings
10:53am, Monday, 24'th Feb 2025
Pfizer: What The Summit Therapeutics Deal Brings
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:05am, Monday, 24'th Feb 2025
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus
09:30am, Monday, 24'th Feb 2025
Stocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic.
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
08:33am, Monday, 24'th Feb 2025
PHILADELPHIA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Berger Montague advises shareholders of Pfizer Inc. (“Pfizer” or the “Company”) (NYSE: PFE) about an investigation into Pfizer's Board of Direct
Don't Get Left Behind - The Great Rotation Into Dividend Stocks Is Here
07:30am, Monday, 24'th Feb 2025
Despite significant market events, industrial and tech stocks have had similar returns since 2020, indicating a potential long-term rotation favoring value stocks. Higher inflation and interest rates
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
03:26pm, Sunday, 23'rd Feb 2025
Buying quality stocks when they're unpopular can be very rewarding.
3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold Forever
04:53am, Sunday, 23'rd Feb 2025
I went to a Prince concert years ago. He opened with one of his hit songs from the '80s -- Let's Go Crazy.
Pfizer: No More Growth - Still A Worthy Dividend Buy
09:00am, Saturday, 22'nd Feb 2025
PFE's sell-off triggers a rich dividend yield of 6.73% and double digits capital appreciation prospects, thanks to management's focus to "enhancing long-term shareholder value." Despite the patent cli
3 Magnificent Dividend Growth Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade
03:57am, Saturday, 22'nd Feb 2025
There are many ways to make money on Wall Street, but some methods are a lot more reliable than others. Whether you're looking for a way to raise the stream of passive income your portfolio produces o
2 No-Brainer Healthcare Stocks to Buy With $500 Right Now
05:50am, Friday, 21'st Feb 2025
Looking for a good area in which to invest? Consider the healthcare sector.
